Radiation with chemo and immunotherapy for mouth cancer
Part of Cancer clinical trials.
This trial tests a new radiation technique combined with chemotherapy and immunotherapy for patients with mouth cancer that has not spread. It aims to improve treatment effectiveness for larger tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have mouth cancer that has not spread to other parts of the body, confirmed by a biopsy.
- Your tumor is at least 3 centimeters, and if it has spread to lymph nodes, those are also at least 3 centimeters.
- Your cancer can be surgically removed.
- You are able to perform your daily activities without major limitations (Zubrod score 0 or 1).
- You have not had prior radiation to the head and neck area or chemotherapy for this cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a personalized approach to radiation therapy after surgery, guided by a special lymph node biopsy (sentinel node biopsy), can effectively treat mouth cancer while reducing side effects. It is for people whose cancer is on one side of the mouth and has not spread to the other side of the neck or beyond.
This trial tests whether giving a type of radiation therapy (proton or photon) along with the immunotherapy drug pembrolizumab before surgery is safe and effective for people with certain oral cavity cancers. The goal is to see if this combination can shrink the tumor and improve outcomes.
This trial tests a new way of giving radiation therapy for throat cancer combined with chemotherapy and immunotherapy. It aims to see if the experimental radiation pattern can safely and effectively treat larger tumors while limiting side effects.
This trial tests whether giving radiation after surgery can lower the risk of the cancer coming back for people with oral tongue cancer that has specific high-risk features but not advanced spread. It aims to find the best treatment plan for patients with certain tumor characteristics.
This trial tests whether adding targeted radiation (SBRT) to a combination of chemotherapy and immunotherapy before surgery can improve outcomes for people with advanced mouth or throat cancer. It aims to shrink the tumor more effectively before removal.
This trial tests combining radiation therapy with immunotherapy and chemotherapy before surgery for advanced oral or throat cancer. The goal is to see if this approach can shrink the tumor and improve treatment outcomes.
Hear when a new Oral Cavity Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.